✦ LIBER ✦

Weekly regimen of irinotecan/docetaxel in previously treated non-small cell lung cancer patients and correlation with uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphism

✍ Scribed by Albert Font; José Miguel Sánchez; Miquel Tarón; Eva Martinez-Balibrea; José Javier Sánchez; José Luis Manzano; Mireia Margelí; Martin Richardet; Agustí Barnadas; Albert Abad; Rafael Rosell

Book ID: 111559029
Publisher: Springer US
Year: 2003
Tongue: English
Weight: 140 KB
Volume: 21
Category: Article
ISSN: 0167-6997
DOI: 10.1023/a:1026251202137

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II Pharmacokinetic and Pharmacog

Phase I/II Pharmacokinetic and Pharmacogenomic Study of UGT1A1 Polymorphism in Elderly Patients With Advanced Non–Small Cell Lung Cancer Treated With Irinotecan

✍ Yamamoto, N; Takahashi, T; Kunikane, H; Masuda, N; Eguchi, K; Shibuya, M; Takeda 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 230 KB

Prognostic advantage of irinotecan dose

Prognostic advantage of irinotecan dose escalation according to uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) genotyping in patients with metastatic colorectal cancer treated with bevacizumab combined with 5-fluorouracil/leucovorin with irinotecan in a first-line setting

✍ Lu, Chien-Yu; Huang, Ching-Wen; Hu, Huang-Ming; Tsai, Hsiang-Lin; Huang, Chun-Mi 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 455 KB

595 UGT1A1 polymorphisms correlate with

595 UGT1A1 polymorphisms correlate with adverse side effects and clinical response in metastatic colorectal cancer patients treated with irinotecan

✍ E. Marcuello; A. Menoyo; E. Del Rio; M. Gomez-Pardo; M. Balcells; M. Baiget 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 171 KB

A phase I study of S-1 and irinotecan co

A phase I study of S-1 and irinotecan combination therapy in previously treated advanced non-small cell lung cancer patients

✍ Satoshi Yoda; Kenzo Soejima; Hiroyuki Yasuda; Katsuhiko Naoki; Ichiro Kawada; Hi 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 166 KB

Docetaxel plus nintedanib versus docetax

Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial

✍ Reck, Martin; Kaiser, Rolf; Mellemgaard, Anders; Douillard, Jean-Yves; Orlov, Se 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 382 KB

Phase II study of S-1 and docetaxel for

Phase II study of S-1 and docetaxel for previously treated patients with locally advanced or metastatic non-small cell lung cancer

✍ Kazuhiro Yanagihara; Kenichi Yoshimura; Miyuki Niimi; Hiroyasu Yasuda; Takahiko 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 260 KB